Sabine Hoves

Roche Pharma AG (Germany) — Germany

Immunology and Microbiology · Life Sciences

27h-index6.6kcitations87works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(39), Immunotherapy and Immune Responses(23), Immune Cell Function and Interaction(22), Cancer Research and Treatments(22), Cancer Immunotherapy and Biomarkers(19)

Publications87 total

Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
Frontiers in Immunology·2024· 1 citedOpen Access
Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma
Med·2024· 10 citedOpen Access
Abstract 2342: RO7119929, a TLR7 agonist prodrug, induces local inflammation of the tumor microenvironment (TME) by reprogramming myeloid cells in patients (pts) with advanced primary or metastatic liver cancers
Cancer Research·2023· 2 cited
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023· 1 citedOpen Access
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Carola H. Ries(20), Max Schnurr(8), Michael A. Cannarile(7), Stefan Endres(7), Martin Fleck(7), Stefan W. Krause(6), Jonathan Ellermeier(6), Jiwu Wei(6), Peter Duewell(6), Andréas Mackensen(5), Valeria Runza(5), Dominik Rüttinger(5), Michele De Palma(5), Damya Laoui(5), Mareike R. Stieg(5), Tina Adunka(5), Daniel Noerenberg(5), Hans‐Joachim Anders(5), Doris Mayr(5), Hendrik Poeck(5)